| Trial Identifier: | D5570C00002 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Juvenile Diabetes Research Foundation
|
| NCTID:: | NCT02500979 |
| Start Date: | August 2015 |
| Primary Completion Date: | August 2016 |
| Study Completion Date: | August 2016 |
| Condition: | Diabetes: Type 1 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English translation |
| Country | Location |
|---|---|
| United States of America, CA | Chula Vista, CA, United States of America, 91911 |
| United States of America, OR | Portland, OR, United States of America, 97239 |
| United States of America, TN | Chattanooga, TN, United States of America, 37411 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company